Needle-Free Delivery Systems for mRNA Vaccines Market
完整報告名稱與涵蓋範圍
Needle-Free Delivery Systems for mRNA Vaccines Market Size, Share & Trends Analysis Report, By Technology (Spring-Powered Jet Injectors, Gas-Powered Jet Injectors, Microneedle Patches and Intradermal Systems, Mucosal (Intranasal and Oral) Delivery Systems), By Delivery Route (Intradermal, Intramuscular and Subcutaneous, Mucosal), By Application (Pandemic and Outbreak Response Vaccination, Routine and Seasonal Immunization Programs, Clinical Trial and Investigational Use), By End User, By Region, and Segment Forecasts, 2026-2035
報告摘要
The needle-free delivery systems for mRNA vaccines market covers spring- and gas-powered jet injectors, dissolving and coated microneedle patches, intradermal delivery systems and mucosal delivery technologies used to administer nucleic acid vaccines without hypodermic needles, together with associated disposables. Conventional needle-and-syringe presentations and drug delivery devices for non-vaccine biologics are excluded.
Interest was catalysed by pandemic-era deployment of needle-free jet injectors for DNA and mRNA vaccines and by evidence that intradermal and jet delivery can achieve comparable or improved immune responses at reduced doses, which matters for supply-constrained campaigns and for cost-sensitive immunization programs. Devices eliminate needle-stick injuries and sharps waste, simplify administration by non-clinical staff and, in the case of microneedle patches, offer thermostable, self-administered formats that could transform distribution in low-resource settings. Compatibility of lipid nanoparticle formulations with high-velocity jet delivery, regulatory acceptance of device-vaccine combinations and procurement decisions by governments and global health agencies will determine adoption pace.
North America and Europe lead device development, while India, Latin America and Africa represent large potential deployment markets through public immunization programs. Competition involves needle-free injector specialists, microneedle developers, drug delivery device companies and vaccine developers partnering on combination products.
The InsightAce study delivers revenue forecasts in US$ across all technology, delivery route, application and end user and regional segments for 2026-2035, alongside segment-level trend analysis, competitive landscape assessment and detailed company profiling.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Needle-Free Delivery Systems for mRNA Vaccines Market Snapshot
Chapter 4. Global Needle-Free Delivery Systems for mRNA Vaccines Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Technology Estimates & Trend Analysis
5.1. Technology & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Technology:
5.2.1. Spring-Powered Jet Injectors
5.2.2. Gas-Powered Jet Injectors
5.2.3. Microneedle Patches and Intradermal Systems
5.2.4. Mucosal (Intranasal and Oral) Delivery Systems
Chapter 6. Market Segmentation 2: By Delivery Route Estimates & Trend Analysis
6.1. Delivery Route & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Delivery Route:
6.2.1. Intradermal
6.2.2. Intramuscular and Subcutaneous
6.2.3. Mucosal
Chapter 7. Market Segmentation 3: By Application Estimates & Trend Analysis
7.1. Application & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Application:
7.2.1. Pandemic and Outbreak Response Vaccination
7.2.2. Routine and Seasonal Immunization Programs
7.2.3. Clinical Trial and Investigational Use
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. End User & Market Share, 2026 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by End User:
8.2.1. Government Immunization Programs
8.2.2. Hospitals and Vaccination Clinics
8.2.3. Vaccine Developers and CDMOs
Chapter 9. Needle-Free Delivery Systems for mRNA Vaccines Market: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. South Korea
9.3.5. Australia
9.3.6. Southeast Asia
9.3.7. Rest of Asia Pacific
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Middle East & Africa
9.5.1. GCC Countries
9.5.2. South Africa
9.5.3. Rest of Middle East & Africa
Chapter 10. Competitive Landscape
10.1. Company Market Positioning Analysis
10.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 11. Company Profiles
11.1. PharmaJet, Inc.
11.2. Inovio Pharmaceuticals, Inc. (CELLECTRA)
11.3. Micron Biomedical, Inc.
11.4. Vaxxas Pty Ltd.
11.5. Zosano Legacy Microneedle Platforms
11.6. LTS Lohmann Therapie-Systeme AG
11.7. Becton, Dickinson and Company (Intradermal Systems)
11.8. Portal Instruments, Inc.
11.9. Enesi Pharma Ltd.
11.10. Crossject SA
11.11. Medical International Technology Inc.
11.12. Antares Pharma (Halozyme Therapeutics, Inc.)
11.13. Vaxess Technologies, Inc.
11.14. NanoPass Technologies Ltd.
11.15. Zydus Lifesciences Ltd. (Needle-Free DNA Vaccine Deployment)
圖表清單 List of Tables & Figures
Table 1. Global Needle-Free Delivery Systems for mRNA Vaccines Market Revenue Forecast by Technology, 2026-2035 (US$ Mn)
Figure 1. Global Needle-Free Delivery Systems for mRNA Vaccines Market Segmentation and Scope Overview
Table 2. Global Needle-Free Delivery Systems for mRNA Vaccines Market Revenue Forecast by Delivery Route, 2026-2035 (US$ Mn)
Figure 2. Global Needle-Free Delivery Systems for mRNA Vaccines Market Share by Technology, 2026 & 2035
Table 3. Global Needle-Free Delivery Systems for mRNA Vaccines Market Revenue Forecast by Application, 2026-2035 (US$ Mn)
Figure 3. Needle-Free Delivery Technology Comparison for Nucleic Acid Vaccines: Jet, Microneedle and Mucosal
Table 4. Global Needle-Free Delivery Systems for mRNA Vaccines Market Revenue Forecast by End User, 2026-2035 (US$ Mn)
Figure 4. Dose-Sparing and Immunogenicity Evidence for Intradermal mRNA Delivery
Table 5. Global Needle-Free Delivery Systems for mRNA Vaccines Market Revenue Forecast by Region, 2026-2035 (US$ Mn)
Figure 5. Asia Pacific Needle-Free Delivery Systems for mRNA Vaccines Growth Opportunity Analysis
Table 6. North America Needle-Free Delivery Systems for mRNA Vaccines Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. Competitive Positioning of Key Needle-Free Delivery Systems for mRNA Vaccines Market Participants
Table 7. Europe Needle-Free Delivery Systems for mRNA Vaccines Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 7. Porter's Five Forces Analysis of the Global Needle-Free Delivery Systems for mRNA Vaccines Market
Table 8. Asia Pacific Needle-Free Delivery Systems for mRNA Vaccines Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 8. Procurement Pathways for Needle-Free Systems in Public Immunization Programs
Table 9. Strategic Developments of Leading Needle-Free Delivery Systems for mRNA Vaccines Market Participants, 2023-2026
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們